Home / Brands / Preferred Pharmaceuticals
Preferred Pharmaceuticals Recalls
55 recalls on record · August 29, 2018 to April 15, 2026 · Drugs
Recalls by year
18
19
20
21
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 15, 2026DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg
Hazard: Lack of Assurance of Sterility
December 24, 2025DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferre
Hazard: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
May 7, 2025DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC
Hazard: cGMP Deviations
September 4, 2024DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisi
Hazard: Failed Impurities/Degradation Specifications - at 18-month Stability testing
May 29, 2024DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Hazard: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
July 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-
Hazard: Failed Stability Specifications
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDC 68788-9868-
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle (NDC 68788-9869-9); b) 60-count bottle (NDC 68788-9869-
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703,
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703,
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 6
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 6878
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 6
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6)
Hazard: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595
Hazard: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenrid
Hazard: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
February 1, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharma
Hazard: Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.
June 1, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5 mg, Pkg Size: 30, NDC: 68788-7758-03.
Hazard: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
June 1, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.
Hazard: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
May 4, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
Hazard: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.